Objective This study aimed to evaluate the prevalence and predictors of cardiovascular disease (CVD), chronic kidney disease ...
A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...
The PanCAN Patient Services team is here for patients and their loved ones as they navigate clinical trials. Our Case Managers offer personal, one-to-one support at every step of the search and ...
Clinical evidence is always evolving, but traditional clinical process map development and EHR build cycles often take months ...
After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...
New York City-based Mount Sinai’s Tisch Cancer Center has launched a new AI platform designed to help more cancer patients across its health system find and enroll in clinical trials. The platform, ...
Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...
Optimising RSV sample handling and laboratory workflows to support faster, more efficient clinical trial delivery.
World-leading challenge study expertise helping deliver scalable, high-quality outpatient vaccine trials in healthy ...
Success rates in phase II and phase III clinical trials are recognized as two of the most powerful drivers of overall efficiency in drug development (Nat. Rev. Drug Disc. 23, 656–657; 2024). With the ...
The future of cancer drug research just might be in Omaha, Nebraska, between a Panda Express and a Mattress Firm. A big draw is speed: Nordquist says he can open a trial in as little as two weeks, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results